IBD (Inspire Corporate Bond ETF) Stock Analysis - AI Report

Inspire Corporate Bond ETF (IBD) is a publicly traded the market company. As of May 21, 2026, IBD trades at $23.80 with a market cap of $0 and a P/E ratio of 0.00. IBD moved +0.00% today. Year to date, IBD is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on IBD?

Rallies AI research for IBD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

IBD Key Metrics

Key financial metrics for IBD
MetricValue
Price$23.80
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume139.86K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest IBD News

IBD Analyst Consensus

IBD analyst coverage data. Average price target: $0.00.

Common questions about IBD

What is the AI research view on IBD?
Rallies AI research for IBD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for IBD?
Rallies AI research for IBD combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is IBD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBD. It does not provide personalized investment advice.
IBD

IBD